You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • PO.6.130 Rapid efficacy of anifrolumab in multiple subtypes of recalcitrant cutaneous lupus erythematosus parallels discrete changes in transcriptomic and cellular biomarkers

Citation Tools

Article menu

Download PDFPDF

Friday 07 October 2022 from 13:00 to 14:10
Po.6 E- poster session 6: management and recommendations, old and new therapies/biologics
PO.6.130 Rapid efficacy of anifrolumab in multiple subtypes of recalcitrant cutaneous lupus erythematosus parallels discrete changes in transcriptomic and cellular biomarkers

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Carter L, Wigston Z, Laws P, et al
PO.6.130 Rapid efficacy of anifrolumab in multiple subtypes of recalcitrant cutaneous lupus erythematosus parallels discrete changes in transcriptomic and cellular biomarkers
Lupus Science & Medicine 2022;9:doi: 10.1136/lupus-2022-elm2022.151